The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice

Neointimal formation and atherogenesis are major vascular complications following percutaneous coronary intervention, and there is lack of pharmacological therapy. This study was aimed to examine the effect of forskolin (FSK), a cyclic adenosine monophosphate (cAMP)‐elevating agent, on vascular resp...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cell Mol Med
Päätekijät: Hao, Huifeng, Ma, Xiaoyan, Chen, Hong, Zhu, Liyuan, Xu, Zhenyu, Li, Qiaoling, Xu, Chuansheng, Zhang, Yuze, Peng, Zekun, Wang, Miao
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7520276/
https://ncbi.nlm.nih.gov/pubmed/32810369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15476
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia